Nicholas I. Obiri
- Immunology top 1%
- Oncology top 5%
- Biotechnology top 1%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Raj K. PuriWaldemar DebinskiTakashi MurataIra PastanWarren J. LeonardPamela LelandM. Javad AmanNahid Tayebi
- Topics
- Toxin Mechanisms and Immunotoxins (17 papers)Monoclonal and Polyclonal Antibodies Research (13 papers)Transgenic Plants and Applications (9 papers)
- Cited by
- ImmunologyBiotechnologyOncology
- Partner nations
- United StatesThailandJapan
In The Last Decade
Nicholas I. Obiri
24 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Immunology 1.6k
- Oncology 574
- Biotechnology 447
- Molecular Biology 372
- Radiology, Nuclear Medicine and Imaging 358
Countries citing papers authored by Nicholas I. Obiri
This map shows the geographic impact of Nicholas I. Obiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas I. Obiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas I. Obiri more than expected).
Fields of papers citing papers by Nicholas I. Obiri
This network shows the impact of papers produced by Nicholas I. Obiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas I. Obiri. The network helps show where Nicholas I. Obiri may publish in the future.
Co-authorship network of co-authors of Nicholas I. Obiri
This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas I. Obiri. A scholar is included among the top collaborators of Nicholas I. Obiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas I. Obiri. Nicholas I. Obiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 99 | |
| 3 | 46 | |
| 4 | 115 | |
| 5 | 135 | |
| 6 | 57 | |
| 7 | 78 | |
| 8 | 37 | |
| 9 | 252 | |
| 10 | 183 | |
| 11 | 229 | |
| 12 | 15 | |
| 13 | Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response. | 15 |
| 14 | 17 | |
| 15 | 113 | |
| 16 | 153 | |
| 17 | Immunostaining of interleukin-4 receptor on human renal cell carcinoma. | 19 |
| 18 | Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro. | 13 |
| 19 | 26 | |
| 20 | 9 |
About Nicholas I. Obiri
Nicholas I. Obiri is a scholar working on Biotechnology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 2.0k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (17 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Transgenic Plants and Applications (9 papers). The work is most often cited by research in Immunology (1.6k citations), Biotechnology (447 citations) and Oncology (574 citations). Nicholas I. Obiri has collaborated with scholars based in United States, Thailand and Japan. Frequent co-authors include Raj K. Puri, Waldemar Debinski, Takashi Murata, Ira Pastan, Warren J. Leonard, Pamela Leland, M. Javad Aman, Nahid Tayebi, William S. Modi and S K Powers. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.